Broncus Holding Corporation Acquires Target Company Shares for US$15 Million
I'm PortAI, I can summarize articles.
Broncus Holding Corporation's subsidiary has signed a share transfer agreement to acquire shares of a target company for US$15 million. The agreement, dated December 29, 2025, is subject to conditions including the accuracy of representations at closing. The acquisition is expected to be completed by March 31, 2026, unless otherwise agreed. Broncus expressed confidence in the target company's business prospects, particularly in interventional treatments for mitral and tricuspid valves.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments